Reporter April 2 2021
Apr. 2, 2021—Kristopher Kast, MD, assistant professor in the Department of Psychiatry and Behavioral Sciences and clinical director of Vanderbilt’s Addiction Consult Service, has discovered a strong association between attention-deficit/hyperactivity disorder (ADHD) pharmacotherapy and retention rates for substance use disorder (SUD) treatment.
Apr. 2, 2021—Vanderbilt University Medical Center is participating in a national phase 1 clinical trial in healthy adults of an investigational vaccine against the B.1.351 variant of the COVID-19 virus that was first identified in South Africa.
Apr. 1, 2021—Through a Vanderbilt University School of Medicine student-led effort, Dixie Place, the city street that runs between the Medical Center’s Central Garage and the Oxford House building on 21st Avenue South, is being renamed Vivien Thomas Way.
Apr. 1, 2021—Zach Lloyd was only 37 years old with no pre-existing health conditions, but COVID-19 was bringing him within an inch of his life.
Apr. 1, 2021—Triple-negative breast cancer cells engage in a “glutamine steal” — outcompeting T cells for the nutrient glutamine and impairing their ability to kill tumor cells, Vanderbilt researchers have discovered.
Apr. 1, 2021—New investments in clinical programs at Vanderbilt University Medical Center are increasingly contingent upon studies to validate claims of benefit and the potential for scalability and spread.
Apr. 1, 2021—Despite an impressive vaccination effort that exceeds 2 million shots a day, rates of COVID-19 are again on the rise in several parts of the United States, as is the spread of highly transmissible variants of the virus.
Apr. 1, 2021—Analysis seeks to better manage infection in dialysis patients